About Raydiant Oximetry
Raydiant Oximetry is a company based in San Ramon (United States) founded in 2015 by Neil Ray. It operates as a HealthTech. Raydiant Oximetry has raised $25.7 million across 14 funding rounds from investors including March of Dimes, HHS and VCI Global. Raydiant Oximetry offers products and services including Lumerah™. Raydiant Oximetry operates in a competitive market with competitors including kegg, Femometer, HeraMED, Noninvasix and OBMedical, among others.
- Headquarter San Ramon, United States
- Founders Neil Ray
-
Sectors
ConsumerHealthcare Technology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Raydiant Oximetry, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.7 M (USD)
in 14 rounds
-
Latest Funding Round
$7.5 M (USD), Series A
May 28, 2024
-
Investors
March of Dimes
& 17 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Raydiant Oximetry
Raydiant Oximetry offers a comprehensive portfolio of products and services, including Lumerah™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Noninvasive fetal pulse oximeter for oxygenation monitoring.
Unlock access to complete
Unlock access to complete
Funding Insights of Raydiant Oximetry
Raydiant Oximetry has successfully raised a total of $25.7M across 14 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series A — $7.5M
-
First Round
First Round
(15 Jul 2018)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series A - Raydiant Oximetry | Valuation | Cross Border Impact Ventures | |
| Feb, 2023 | Amount | Series A - Raydiant Oximetry | Valuation | March of Dimes |
|
| Jul, 2021 | Amount | Series A - Raydiant Oximetry | Valuation | Avestria Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Raydiant Oximetry
Raydiant Oximetry has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include March of Dimes, HHS and VCI Global. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on health technology for global impact.
|
Founded Year | Domain | Location | |
|
Venture capital investment opportunities are provided for accredited investors.
|
Founded Year | Domain | Location | |
|
Avestria Ventures is focused on funding women's health and life science ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Raydiant Oximetry
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Raydiant Oximetry
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Raydiant Oximetry Comparisons
Competitors of Raydiant Oximetry
Raydiant Oximetry operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as kegg, Femometer, HeraMED, Noninvasix and OBMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fertility tracking and pelvic health solutions are provided by kegg.
|
|
| domain | founded_year | HQ Location |
Basal body temperature is tracked by Femometer for cycle monitoring.
|
|
| domain | founded_year | HQ Location |
Smartphone-based devices for pregnancy monitoring are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a fetal blood oxygenation monitoring device
|
|
| domain | founded_year | HQ Location |
Fetal heart rate and contractions are monitored via wireless electrodes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Raydiant Oximetry
Frequently Asked Questions about Raydiant Oximetry
When was Raydiant Oximetry founded?
Raydiant Oximetry was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is Raydiant Oximetry located?
Raydiant Oximetry is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Who is the current CEO of Raydiant Oximetry?
Neil Ray is the current CEO of Raydiant Oximetry. They have also founded this company.
Is Raydiant Oximetry a funded company?
Raydiant Oximetry is a funded company, having raised a total of $25.7M across 14 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jul 15, 2018.
What does Raydiant Oximetry do?
Raydiant Oximetry, Inc. is focused on advancing fetal health monitoring during childbirth. The company is developing Lumerah, a noninvasive fetal pulse oximeter designed to measure fetal oxygen levels accurately. This technology aims to reduce maternal and neonatal mortality and morbidity by providing healthcare professionals with reliable data for decision-making during labor and delivery. Operating in the healthcare sector, specifically in medical devices, solutions are targeted at improving outcomes in obstetrics. Partnerships with organizations like GE HealthCare further support the enhancement of fetal monitoring capabilities.
Who are the top competitors of Raydiant Oximetry?
What products or services does Raydiant Oximetry offer?
Raydiant Oximetry offers Lumerah™.
Who are Raydiant Oximetry's investors?
Raydiant Oximetry has 18 investors. Key investors include March of Dimes, HHS, VCI Global, AngelMD, and Global Health Impact Network.